Covered recipient · General Payments record
TATYANA SIMUNI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$298,890.85
- Reported across 217 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $15,001.00 | 11 |
| Food and Beverage | $71.43 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $4,461.00 | 2 |
| F. Hoffmann-La Roche AG | $3,400.00 | 2 |
| GE HEALTHCARE | $3,000.00 | 2 |
| Genentech, Inc. | $2,415.00 | 3 |
| UCB SA | $1,100.00 | 1 |
| Eli Lilly and Company | $625.00 | 1 |
| Amneal Pharmaceuticals LLC | $71.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals LLC | $71.43 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139202252 | CMS |
| Eli Lilly and Company | $625.00 | 11/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135479134 | CMS |
| F. Hoffmann-La Roche AG | $600.00 | 10/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133122420 | CMS |
| F. Hoffmann-La Roche AG | $2,800.00 | 10/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133122424 | CMS |
| GE HEALTHCARE | $1,500.00 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1144691017 | CMS |
| GE HEALTHCARE | $1,500.00 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1144691045 | CMS |
| Genentech, Inc. | $1,380.00 | 06/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133122428 | CMS |
| Genentech, Inc. | $690.00 | 07/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133122432 | CMS |
| Genentech, Inc. | $345.00 | 10/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133122436 | CMS |
| Neurocrine Biosciences, Inc. | $1,837.00 | 04/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150870723 | CMS |
| Neurocrine Biosciences, Inc. | $2,624.00 | 10/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150866749 | CMS |
| UCB SA | $1,100.00 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113951051 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.